Spherix Global Insights (@spherixinsights) 's Twitter Profile
Spherix Global Insights

@spherixinsights

Spherix Global Insights is a leading provider of market research, business intelligence and advisory services to the global life sciences industry.

ID: 4025773487

linkhttp://www.spherixglobalinsights.com/ calendar_today23-10-2015 17:47:03

875 Tweet

326 Takipçi

817 Takip Edilen

Spherix Global Insights (@spherixinsights) 's Twitter Profile Photo
Spherix Global Insights
@spherixinsights

2 years ago

Eli Lilly and Company released phase 3 trial data for donanemab with results that suggest more slowing of cognitive decline than has been seen with prior Alzheimer’s therapies, including the recently approved Leqembi (from Eisai/Biogen). Read More: hubs.la/Q01Y9S3q0

Eli Lilly and Company released phase 3 trial data for donanemab with results that suggest more slowing of cognitive decline than has been seen with prior Alzheimer’s therapies, including the recently approved Leqembi (from Eisai/Biogen). Read More: hubs.la/Q01Y9S3q0